D.Western Therapeutics Institute, Inc. FY2025 Q3 Earnings Report | IR Tracker

D.Western Therapeutics Institute, Inc. FY2025 Q3 Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥297M
Operating Income: ¥-478M
Net Income: ¥-727M
EPS: ¥-10.75

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥297M	¥348M	-14.7%
Cost of Sales	¥34M	-	-
Gross Profit	¥315M	-	-
SG&A Expenses	¥963M	-	-
Operating Income	¥-478M	¥-647M	+26.1%
Non-operating Income	¥152,000	-	-
Non-operating Expenses	¥18M	-	-
Ordinary Income	¥-491M	¥-665M	+26.2%
Profit Before Tax	¥-726M	-	-
Income Tax Expense	¥1M	-	-
Net Income	¥-727M	-	-
Net Income Attributable to Owners	¥-492M	¥-727M	+32.3%
Total Comprehensive Income	¥-492M	¥-727M	+32.3%
Interest Expense	¥4M	-	-
Basic EPS	¥-10.75	¥-21.61	+50.3%
Dividend Per Share	¥0.00	¥0.00	-

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥2.02B	¥1.48B	+¥543M
Cash and Deposits	¥1.65B	¥1.13B	+¥528M
Accounts Receivable	¥144M	¥125M	+¥19M
Non-current Assets	¥160M	¥194M	¥-34M
Property, Plant & Equipment	¥10M	¥11M	¥-1M

Profitability Ratios

Item	Value
Net Profit Margin	-165.7%
Gross Profit Margin	106.1%
Current Ratio	915.4%
Quick Ratio	915.4%
Debt-to-Equity Ratio	0.49x
Interest Coverage Ratio	-134.72x
Effective Tax Rate	-0.2%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	-14.9%

Item	Value
Shares Outstanding (incl. Treasury)	53.14M shares
Treasury Stock	286 shares
Average Shares Outstanding	45.85M shares
Book Value Per Share	¥27.55

Dividend Information

Item	Amount
Q2 Dividend	¥0.00
Year-End Dividend	¥0.00

Full Year Forecast

Item	Forecast
Net Sales Forecast	¥400M
Operating Income Forecast	¥-670M
Ordinary Income Forecast	¥-680M
Net Income Attributable to Owners Forecast	¥-680M
Basic EPS Forecast	¥-15.88
Dividend Per Share Forecast	¥0.00

Disclaimer

This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.